AMPICILLIN AND SULBACTAM

Ampicillin And Sulbactam Adverse Events Reported to the FDA Over Time

How are Ampicillin And Sulbactam adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ampicillin And Sulbactam, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ampicillin And Sulbactam is flagged as the suspect drug causing the adverse event.

Most Common Ampicillin And Sulbactam Adverse Events Reported to the FDA

What are the most common Ampicillin And Sulbactam adverse events reported to the FDA?

Pneumonia	28 (1.69%)
Enterocolitis Haemorrhagic	24 (1.45%)
Anaphylactic Reaction	23 (1.39%)
Drug Interaction	23 (1.39%)
Jaundice	21 (1.27%)
Diarrhoea	19 (1.14%)
Rash	19 (1.14%)
Hypersensitivity	17 (1.02%)
Septic Shock	17 (1.02%)
Toxic Epidermal Necrolysis	17 (1.02%)
Renal Failure Acute	16 (.96%)
	Show More
Stevens-johnson Syndrome	16 (.96%)
Acute Respiratory Distress Syndrome	15 (.9%)
Alanine Aminotransferase Increased	15 (.9%)
Pyrexia	15 (.9%)
Tachycardia	14 (.84%)
Culture Stool Positive	13 (.78%)
Liver Injury	13 (.78%)
Pruritus	13 (.78%)
Vomiting	13 (.78%)
Acute Generalised Exanthematous Pus...	12 (.72%)
Clostridial Infection	12 (.72%)
Hepatitis Toxic	12 (.72%)
Hepatitis Acute	11 (.66%)
Liver Disorder	11 (.66%)
Angioedema	10 (.6%)
Blood Pressure Increased	10 (.6%)
Clostridium Difficile Colitis	10 (.6%)
Condition Aggravated	10 (.6%)
Drug Ineffective	10 (.6%)
Pseudomembranous Colitis	10 (.6%)
Rash Maculo-papular	10 (.6%)
Sepsis	10 (.6%)
Drug Hypersensitivity	9 (.54%)
General Physical Condition Abnormal	9 (.54%)
Haemorrhage Intracranial	9 (.54%)
Hypoglycaemia	9 (.54%)
International Normalised Ratio Incr...	9 (.54%)
Nausea	9 (.54%)
Rash Generalised	9 (.54%)
Anaphylactic Shock	8 (.48%)
Cholecystitis	8 (.48%)
Dehydration	8 (.48%)
Erythema	8 (.48%)
Hypotension	8 (.48%)
Infusion Related Reaction	8 (.48%)
Klebsiella Infection	8 (.48%)
Liver Function Test Abnormal	8 (.48%)
Malaise	8 (.48%)
Rash Macular	8 (.48%)
Acute Respiratory Failure	7 (.42%)
Aspartate Aminotransferase Increase...	7 (.42%)
Bacteraemia	7 (.42%)
Cardiac Arrest	7 (.42%)
Hepatitis	7 (.42%)
Multi-organ Failure	7 (.42%)
Quadriparesis	7 (.42%)
Renal Impairment	7 (.42%)
Respiratory Failure	7 (.42%)
Thrombocytopenia	7 (.42%)
Thyrotoxic Crisis	7 (.42%)
Urinary Tract Infection	7 (.42%)
Urticaria	7 (.42%)
Acute Hepatic Failure	6 (.36%)
Autoimmune Thyroiditis	6 (.36%)
Bacterial Infection	6 (.36%)
Benign Prostatic Hyperplasia	6 (.36%)
Bronchospasm	6 (.36%)
Cardiogenic Shock	6 (.36%)
Cholestasis	6 (.36%)
Drug Exposure During Pregnancy	6 (.36%)
Drug Level Decreased	6 (.36%)
Enterocolitis Infectious	6 (.36%)
Gamma-glutamyltransferase Increased	6 (.36%)
Hepatic Failure	6 (.36%)
Inflammation	6 (.36%)
Palpitations	6 (.36%)
Panic Attack	6 (.36%)
Platelet Count Decreased	6 (.36%)
Pulmonary Embolism	6 (.36%)
Rash Erythematous	6 (.36%)
Rash Morbilliform	6 (.36%)
Restlessness	6 (.36%)
Staphylococcal Infection	6 (.36%)
Ventricular Fibrillation	6 (.36%)
Anaemia	5 (.3%)
Blister	5 (.3%)
Blood Bilirubin Increased	5 (.3%)
Brain Oedema	5 (.3%)
C-reactive Protein Increased	5 (.3%)
Cardiac Failure	5 (.3%)
Convulsion	5 (.3%)
Delirium	5 (.3%)
Drug Eruption	5 (.3%)
Dyspnoea	5 (.3%)
Gait Disturbance	5 (.3%)
Hepatic Steatosis	5 (.3%)
Hepatocellular Injury	5 (.3%)
Hyperglycaemia	5 (.3%)
Jaundice Cholestatic	5 (.3%)
Medication Error	5 (.3%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Ampicillin And Sulbactam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ampicillin And Sulbactam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ampicillin And Sulbactam

What are the most common Ampicillin And Sulbactam adverse events reported to the FDA?

Epidermal And Dermal Conditions	174 (10.48%)
Hepatic And Hepatobiliary	123 (7.41%)
Infections - Pathogen Unspecified	102 (6.14%)
Bacterial Infectious	87 (5.24%)
Allergic Conditions	57 (3.43%)
Hepatobiliary	47 (2.83%)
Therapeutic And Nontherapeutic Effe...	43 (2.59%)
Respiratory	42 (2.53%)
Hematology Investigations	37 (2.23%)
Cardiac Arrhythmias	32 (1.93%)
Gastrointestinal Motility And Defec...	32 (1.93%)
	Show More
Gastrointestinal Signs	32 (1.93%)
Gastrointestinal Inflammatory Condi...	28 (1.69%)
Neurological	28 (1.69%)
Lower Respiratory Tract Disorders	27 (1.63%)
Renal Disorders	27 (1.63%)
Fungal Infectious	23 (1.39%)
Microbiology And Serology	23 (1.39%)
Cardiac And Vascular Investigations	21 (1.27%)
Angiedema And Urticaria	17 (1.02%)
Body Temperature Conditions	16 (.96%)
Electrolyte And Fluid Balance Condi...	15 (.9%)
Central Nervous System Vascular	14 (.84%)
Glucose Metabolism Disorders	14 (.84%)
Heart Failures	14 (.84%)
Administration Site Reactions	13 (.78%)
Decreased And Nonspecific Blood Pre...	13 (.78%)
Medication Errors	13 (.78%)
Movement Disorders	13 (.78%)
Thyroid Gland	13 (.78%)
Muscle	12 (.72%)
Anemias Nonhemolytic And Marrow Dep...	11 (.66%)
Protein And Chemistry Analyses	11 (.66%)
Appetite And General Nutritional	10 (.6%)
Ocular Neuromuscular	10 (.6%)
Physical Examination Topics	10 (.6%)
Renal And Urinary Tract Investigati...	10 (.6%)
Bronchial Disorders	9 (.54%)
Cardiac Disorder Signs	9 (.54%)
Chemical Injury And Poisoning	9 (.54%)
Encephalopathies	9 (.54%)
Seizures	9 (.54%)
Tongue Conditions	9 (.54%)
Toxicology And Therapeutic Drug Mon...	9 (.54%)
Anxiety Disorders	8 (.48%)
Coronary Artery	8 (.48%)
Gallbladder	8 (.48%)
Peripheral Neuropathies	8 (.48%)
Water, Electrolyte And Mineral	8 (.48%)
White Blood Cell	8 (.48%)
Enzyme	7 (.42%)
Platelet	7 (.42%)
Skin Vascular Abnormalities	7 (.42%)
Suicidal And Self-injurious Behavio...	7 (.42%)
Changes In Physical Activity	6 (.36%)
Deliria	6 (.36%)
Hemolyses And Related Conditions	6 (.36%)
Mental Impairment	6 (.36%)
Neonatal And Perinatal Conditions	6 (.36%)
Prostatic Disorders	6 (.36%)
Pulmonary Vascular	6 (.36%)
Vascular Hemorrhagic	6 (.36%)
Arteriosclerosis, Stenosis, Vascula...	5 (.3%)
Coagulopathies And Bleeding Diathes...	5 (.3%)
Disturbances In Thinking	5 (.3%)
Gastrointestinal Hemorrhages	5 (.3%)
Hematological And Lymphoid Tissue T...	5 (.3%)
Increased Intracranial Pressure And...	5 (.3%)
Injuries	5 (.3%)
Joint	5 (.3%)
Reproductive Tract And Breast Disor...	5 (.3%)
Spleen, Lymphatic And Reticulendoth...	5 (.3%)
Upper Respiratory Tract Disorders	5 (.3%)
Vascular Inflammations	5 (.3%)
Vision	5 (.3%)
Headaches	4 (.24%)
Metabolic, Nutritional And Blood Ga...	4 (.24%)
Ocular Infections, Irritations And ...	4 (.24%)
Oral Soft Tissue Conditions	4 (.24%)
Schizophrenia And Other Psychotic	4 (.24%)
Skin Appendage Conditions	4 (.24%)
Sleep Disorders	4 (.24%)
Structural Brain	4 (.24%)
Urinary Tract Signs	4 (.24%)
Vascular	4 (.24%)
Vascular Hypertensive	4 (.24%)
Vitamin Related	4 (.24%)
Acid-base	3 (.18%)
Cardiac Valve	3 (.18%)
Gastrointestinal	3 (.18%)
Gastrointestinal Ulceration And Per...	3 (.18%)
Immunology And Allergy	3 (.18%)
Lifestyle Issues	3 (.18%)
Obstetric And Gynecological Therape...	3 (.18%)
Procedural And Device Related Injur...	3 (.18%)
Viral Infectious	3 (.18%)
Embolism And Thrombosis	2 (.12%)
Exocrine Pancreas Conditions	2 (.12%)
Fatal Outcomes	2 (.12%)
Investigations, Imaging And Histopa...	2 (.12%)
Myocardial	2 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ampicillin And Sulbactam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ampicillin And Sulbactam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.